Carl Zeiss Meditec AG Logo

Carl Zeiss Meditec AG

ISIN: DE0005313704 | Ticker: AFX | LEI: 529900GRL4MZ8NMOOK95

About Carl Zeiss Meditec AG

Company Description

Under the umbrella of the MDAX and TecDAX-listed company Carl Zeiss Meditec AG, which is one of the world’s leading medical technology companies, the Medical Technology activities of ZEISS are bundled. Carl Zeiss AG holds ca. 59 percent interest.

The Carl Zeiss Meditec AG has set itself the task to develop innovative products to improve the diagnosis and treatment of diseases. The solutions the Company develops aim to simplify clinical workflows and allow physicians to focus all their attention on their work and their patients. After all, at the end we want the patient to leave the clinic with the best possible outcome and a high level of satisfaction.

Therefor we are guided by our Mission to uniquely enable healthcare professionals worldwide to improve the lives of their patients in ophthalmology, microsurgery and other medical growth sectors and advance the standards of care with our proven medical technology and application competence.

Year founded

1977

Served area

Worldwide

Headcount

3,531

Headquarters

Göschwitzer Straße 51-52, 7745 Jena – Germany

Filings & Publications

2022

Report Q1 H1 Q3 FY
Consolidated Report ENG ENG ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2020

Report Q1 H1 Q3 FY
Consolidated Report GER ENG GER ENG ENG GER ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2019

Report Q1 H1 Q3 FY
Consolidated Report GER ENG GER ENG ENG GER ENG GER
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2018

Report Q1 H1 Q3 FY
Consolidated Report GER ENG GER ENG GER ENG GER ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2017

Report Q1 H1 Q3 FY
Consolidated Report GER ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2023

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2021

Report Q1 H1 Q3 FY
Consolidated Report GER ENG ENG GER
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding

89,440,570

IPO

March 20, 2000

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.